California AIDS R&D grants
State department of health services awards grants for AIDS vaccine research to two California firms, Chiron and Becton Dickinson Monoclonal Center. Chiron is receiving $1.5 mil. from the state for its recombinant AIDS vaccine R&D. Becton Dickinson will receive $400,000 for its program investigating the use of antibodies against the CD-4 AIDS virus receptor.
You may also be interested in...
FDA concluded that original formulation of brain hemorrhage treatment was not discontinued for safety or effectiveness reasons, saying Arbor had other options to reduce risk of confusion between the new and original formulations. But the sponsor argues that withdrawal was part of FDA-approved risk mitigation plan.
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.